These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 21565943

  • 1. Protective effects of PPARγ agonist in acute nephrotic syndrome.
    Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB.
    Nephrol Dial Transplant; 2012 Jan; 27(1):174-81. PubMed ID: 21565943
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
    Yang HC, Ma LJ, Ma J, Fogo AB.
    Kidney Int; 2006 May; 69(10):1756-64. PubMed ID: 16598202
    [Abstract] [Full Text] [Related]

  • 3. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
    Eto N, Wada T, Inagi R, Takano H, Shimizu A, Kato H, Kurihara H, Kawachi H, Shankland SJ, Fujita T, Nangaku M.
    Kidney Int; 2007 Aug; 72(4):455-63. PubMed ID: 17457371
    [Abstract] [Full Text] [Related]

  • 4. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
    Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T.
    Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
    [Abstract] [Full Text] [Related]

  • 5. PPAR-gamma agonist protects podocytes from injury.
    Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB.
    Kidney Int; 2007 Jun; 71(12):1232-9. PubMed ID: 17457378
    [Abstract] [Full Text] [Related]

  • 6. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats.
    Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S.
    Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F168-F178. PubMed ID: 36454699
    [Abstract] [Full Text] [Related]

  • 7. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y.
    Nephrol Dial Transplant; 2009 Aug 01; 24(8):2354-61. PubMed ID: 19297354
    [Abstract] [Full Text] [Related]

  • 8. Podocyte alpha-actinin induction precedes foot process effacement in experimental nephrotic syndrome.
    Smoyer WE, Mundel P, Gupta A, Welsh MJ.
    Am J Physiol; 1997 Jul 01; 273(1 Pt 2):F150-7. PubMed ID: 9249603
    [Abstract] [Full Text] [Related]

  • 9. Paeoniflorin ameliorates Adriamycin-induced nephrotic syndrome through the PPARγ/ANGPTL4 pathway in vivo and vitro.
    Lu R, Zhou J, Liu B, Liang N, He Y, Bai L, Zhang P, Zhong Y, Zhou Y, Zhou J.
    Biomed Pharmacother; 2017 Dec 01; 96():137-147. PubMed ID: 28972886
    [Abstract] [Full Text] [Related]

  • 10. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.
    Agrawal S, Chanley MA, Westbrook D, Nie X, Kitao T, Guess AJ, Benndorf R, Hidalgo G, Smoyer WE.
    Sci Rep; 2016 May 04; 6():24392. PubMed ID: 27142691
    [Abstract] [Full Text] [Related]

  • 11. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models.
    Shen X, Jiang H, Ying M, Xie Z, Li X, Wang H, Zhao J, Lin C, Wang Y, Feng S, Shen J, Weng C, Lin W, Wang H, Zhou Q, Bi Y, Li M, Wang L, Zhu T, Huang X, Lan HY, Zhou J, Chen J.
    Sci Rep; 2016 Sep 01; 6():32087. PubMed ID: 27580845
    [Abstract] [Full Text] [Related]

  • 12. The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes.
    Carrasco AG, Izquierdo-Lahuerta A, Valverde ÁM, Ni L, Flores-Salguero E, Coward RJ, Medina-Gómez G.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Jul 01; 1868(7):159329. PubMed ID: 37156296
    [Abstract] [Full Text] [Related]

  • 13. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH.
    Kidney Int; 2008 Sep 01; 74(5):596-612. PubMed ID: 18509322
    [Abstract] [Full Text] [Related]

  • 14. Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
    Aizawa K, Takeda S, Tashiro Y, Yorozu K, Hirata M, Kanada H, Moriguchi Y, Endo K.
    Am J Nephrol; 2012 Sep 01; 36(5):419-26. PubMed ID: 23128049
    [Abstract] [Full Text] [Related]

  • 15. Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance.
    Brideau G, Doucet A.
    BMC Nephrol; 2010 Jul 22; 11():15. PubMed ID: 20649959
    [Abstract] [Full Text] [Related]

  • 16. Decreased Podocyte Vesicle Transcytosis and Albuminuria in APC C-Terminal Deficiency Mice with Puromycin-Induced Nephrotic Syndrome.
    Hatakeyama S, Tojo A, Satonaka H, Yamada NO, Senda T, Ishimitsu T.
    Int J Mol Sci; 2021 Dec 14; 22(24):. PubMed ID: 34948207
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
    Kawakami H, Kamiie J, Yasuno K, Kobayashi R, Aihara N, Shirota K.
    Nephrol Dial Transplant; 2012 Apr 14; 27(4):1324-30. PubMed ID: 21862459
    [Abstract] [Full Text] [Related]

  • 18. Effects of combination PPARγ agonist and angiotensin receptor blocker on glomerulosclerosis.
    Matsushita K, Yang HC, Mysore MM, Zhong J, Shyr Y, Ma LJ, Fogo AB.
    Lab Invest; 2016 Jun 14; 96(6):602-9. PubMed ID: 26999660
    [Abstract] [Full Text] [Related]

  • 19. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
    Wu JB, Ye SF, Liang CL, Li YC, Yu YJ, Lai JM, Lin H, Zheng J, Zhou JY.
    J Ethnopharmacol; 2014 Feb 12; 151(3):1124-1132. PubMed ID: 24389029
    [Abstract] [Full Text] [Related]

  • 20. Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model.
    Herrmann A, Tozzo E, Funk J.
    Exp Toxicol Pathol; 2012 Jan 12; 64(1-2):45-9. PubMed ID: 20591637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.